[Hepatic encephalopathy--therapy].
Wettstein
M
M
Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf. wettstein@med.uni-duesseldorf.de
Häussinger
D
D
D000284:Administration, Oral; D000641:Ammonia / Q000097:blood; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D018753:Diet, Protein-Restricted; D004151:Dipeptides / Q000627:therapeutic use; D005442:Flumazenil / Q000627:therapeutic use; D018757:GABA Modulators / Q000627:therapeutic use; D006501:Hepatic Encephalopathy / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008107:Liver Diseases / Q000150:complications*
D000900:Anti-Bacterial Agents; D004151:Dipeptides; D018757:GABA Modulators; D005442:Flumazenil; D000641:Ammonia; C002939:ornithylaspartate